Manufacturer of Controlled Substances; Notice of Registration, 17262 [05-6702]
Download as PDF
<![CDATA[
17262
Federal Register / Vol. 70, No. 64 / Tuesday, April 5, 2005 / Notices
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Houba, Inc., to manufacture the listed
basic classes of controlled substances is
consistent with the public interest at
this time. DEA has investigated Houba,
Inc., to ensure that the company’s
registration is consistent with the public
interest. The investigation has included
inspection and testing of the company’s
physical security systems, verification
of the company’s compliance with State
and local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR
1301.33(a), the above named company is
granted registration as a bulk
manufacturer of the basic classes of
controlled substances listed.
Dated: March 25, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–6698 Filed 4–4–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Registration
By notice dated December 21, 2004,
and published in the Federal Register
on January 4, 2005 (70 FR 392–393),
Noramco Inc., Division of OrthoMcNeil, Inc., 500 Old Swedes Landing
Road, Wilmington, Delaware 19801,
made application by renewal and by
letter to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of Dihydrocodeine
(9120), a basic class of controlled
substance listed in Schedule II.
The company plans to manufacture
the listed controlled substance in bulk
for distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Noramco Inc. to manufacture the listed
basic classes of controlled substances is
consistent with the public interest at
this time. DEA has investigated
Noramco Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
VerDate jul<14>2003
19:48 Apr 04, 2005
Jkt 205001
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR
1301.33(a), the above named company is
granted registration as a bulk
manufacturer of the basic classes of
controlled substances listed.
Dated: March 25, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–6695 Filed 4–4–05; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on January 19, 2005,
Rhodes Technologies, 498 Washington
Street, Coventry, Rhode Island 02816,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as a bulk
manufacturer of the basic classes of
controlled substances listed in
Schedules I and II:
Drug Enforcement Administration
Drug
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated December 21, 2004,
and published in the Federal Register
Register on January 4, 2005, (70 FR 393),
Organichem Corporation, 33 Riverside
Avenue, Rensselaer, New York 12144,
made application by letter to the Drug
Enforcement Administration (DEA) to
be registered as a bulk manufacturer of
Hydrocodone (9193) and Fentanyl
(9801), a basic class of controlled
substances listed in Schedule II.
The company plans to manufacture
the listed controlled substances in bulk
for distribution to its customers.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and
determined that the registration of
Organichem Corporation to manufacture
the listed basic classes of controlled
substances is consistent with the public
interest at this time. DEA has
investigated Organichem Corporation to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 823,
and in accordance with 21 CFR
1301.33(a), the above named company is
granted registration as a bulk
manufacturer of the basic classes of
controlled substances listed.
Dated: March 25, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–6702 Filed 4–4–05; 8:45 am]
Tetrahydrocannabinols (7370) .....
Methylphenidate (1724) ................
Codeine (9050) .............................
Dihydrocodeine (9120) .................
Oxycodone (9143) ........................
Hydromorphone (9150) ................
Hydrocodone (9193) .....................
Thebaine (9333) ...........................
Noroxymorphone (9668) ..............
Fentanyl (9801) ............................
Frm 00035
Fmt 4703
Sfmt 4703
I
II
II
II
II
II
II
II
II
II
The company plans to manufacture
the listed controlled substances in bulk
for conversion and distribution to its
customers.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than June 6, 2005.
Dated: March 25, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. 05–6697 Filed 4–4–05; 8:45 am]
BILLING CODE 4410–09–P
BILLING CODE 4410–09–P
PO 00000
Schedule
E:\FR\FM\05APN1.SGM
05APN1
]]>Agencies
[Federal Register Volume 70, Number 64 (Tuesday, April 5, 2005)]
[Notices]
[Page 17262]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-6702]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated December 21, 2004, and published in the Federal
Register Register on January 4, 2005, (70 FR 393), Organichem
Corporation, 33 Riverside Avenue, Rensselaer, New York 12144, made
application by letter to the Drug Enforcement Administration (DEA) to
be registered as a bulk manufacturer of Hydrocodone (9193) and Fentanyl
(9801), a basic class of controlled substances listed in Schedule II.
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Organichem Corporation to manufacture the listed basic classes of
controlled substances is consistent with the public interest at this
time. DEA has investigated Organichem Corporation to ensure that the
company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33(a), the above named company is granted registration as a
bulk manufacturer of the basic classes of controlled substances listed.
Dated: March 25, 2005.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 05-6702 Filed 4-4-05; 8:45 am]
BILLING CODE 4410-09-P
